Literature DB >> 1276474

Complement-mediated granulocyte dysfunction in paroxysmal nocturnal hemoglobinuria.

P R Craddock, J Fehr, H S Jacob.   

Abstract

In paroxysmal nocturnal hemoglobinuria (PNH), infection, both viral and bacterial, disproportionate to the mild neutropenia seen in many such patients is responsible for significant morbidity. We report impaired granulocyte chemotaxis efficiency which may contribute to the problems induced by bacterial infections. PNH (but not normal) granulocytes, after exposure to very small concentrations of activated serum complement components, migrate poorly, as documented by their inhibited chemotaxis toward bacterial products or activated complement components in Boyden chambers. The granulocytes remain intact, excluding trypan blue, phagocytosing, and killing bacteria, despite this activated complement exposure. It is also suggested that this chemotactic defect may involve only a clone of cells, analogous to the clonal lysis of PNH erythrocytes; those few granulocytes capable of migration after exposure to activated complement contain normal quantities of leukocyte alkaline phosphatase (LAP), in contrast to the LAP deficiency of the overall PNH granulocyte population. Since bacterial infection may initiate or potentiate hemolysis, one of the major symptoms of the disease, these results could explain much of the morbidity of PNH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276474

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors.

Authors:  M G Low
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Influence of serum-derived chemotactic factors and bacterial products on human neutrophil chemotaxis.

Authors:  A C Issekutz; W D Biggar
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Specificity and reversibility of chemotactic deactivation of human monocytes.

Authors:  W Falk; E J Leonard
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Paroxysmal nocturnal haemoglobinuria.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

5.  Paroxysmal nocturnal hemoglobinuria--present status and future prospects.

Authors:  W F Rosse
Journal:  West J Med       Date:  1980-03

6.  Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components.

Authors:  R D Nelson; R T McCormack; V D Fiegel; R L Simmons
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism.

Authors:  R D Nelson; R T McCormack; V D Fiegel; M Herron; R L Simmons; P G Quie
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.

Authors:  K M Skubitz; P R Craddock
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.

Authors:  D V Devine; W L Gluck; W F Rosse; J B Weinberg
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.